Total pelvic exenteration – strategy of the surgery
Authors:
V. Visokai; L. Lipská; M. Levý; J. Šimša
Authors place of work:
Chirurgická klinika 1. LF UK a Thomayerovy nemocnice, přednosta: Doc. MUDr. J. Šimša, Ph. D.
Published in the journal:
Rozhl. Chir., 2014, roč. 93, č. 1, s. 38-45.
Category:
Various Specialization
Summary
Introduction:
Total pelvic exenteration (TPE) has a key role in the complex treatment of advanced T4 tumours of the small pelvis, which cannot be radically removed by a less invasive procedure. The aim of this work is to summarize the strategy of TPE, perioperative care of the patients, complications of the intervention and their management.
Methods:
Overview of the current literature and the authors’ experience, based on our own group of 37 patients after TPE performed during the period 1999–2012.
Conclusion:
This article aims to summarize the strategy of TPE, complications and the authors’ own experience.
Key words:
total pelvic exenteration – strategy of the surgery – complications
Zdroje
1. Yamamaura T, Matsuzaki H, Suda T, et al. Clinicopathological variables and p53 over–expression as a prognosticator for hematogenic recurrence in colorectal cancer. J Surg Oncol 1999; 70:1–5.
2. Ahsant A, Clagett P, Edwards M. Complex venous and arterial reconstruction with deep vein after pelvic exenterative surgery: a case report. Am Surg 2006;72:22–24.
3. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcoms in rectal cancer surgery. Ann Surg 2002;235: 449–457.
4. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335: 1055–1059.
5. Lopez MJ, Luna–Pérez P. Composite pelvic exenteration: is it worthwile? Ann Surg Oncol 2003;11:27–33.
6. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934–43.
7. Rutledge FN, Smith JP, Wharton JT, O’Quinn AG. Pelvic exenteration: analysis of 296 patients. Am J Obstet Gynecol 1977;129:881–92.
8. Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol 2006;10:261–8.
9. Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 2013;56:519–31.
10. Roberts WS, Cavanagh D, Bryson SC, Lyman GH, Hewitt S. Major morbidity after pelvic exenteration: a seven-year experience. Obstet Gynecol 1987;69:617–621.
11. Penalver MA, Angioli R, Mirhashemi R, Malik R. Management of early and late complications of ileocolonic continent urinary reservoir (Miami pouch). Gynecol Oncol 1998;69:185–91.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2014 Číslo 1
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Urine derivation after radical cystectomy
- Pelvic exenteration in the treatment of advanced tumours of the small pelvis
-
Is thyroid and parathyroid surgery safe?
Is it suitable for one-day surgery? - Biliary stent as a cause of bowel obstruction